W.W. ten Bokkel Huinink

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.

Elizabeth A. Eisenhauer, W.W. ten Bokkel Huinink, Kenneth D. Swenerton et al. · Journal of Clinical Oncology · 1994 · 641 citations

Medicine, Oncology, Pharmacology +16

Increased Oral Bioavailability of Topotecan in Combination With the Breast Cancer Resistance Protein and P-Glycoprotein Inhibitor GF120918

C.M.F. Kruijtzer, Jos H. Beijnen, Hilde Rosing et al. · Journal of Clinical Oncology · 2002 · 462 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study.

G.J. Creemers, Giorgio Bolis, M. Gore et al. · Journal of Clinical Oncology · 1996 · 386 citations

Medicine, Oncology, Pharmacology +17

Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

Alexandra W. van den Belt‐Dusebout, Janine Nuver, Ronald de Wit et al. · Journal of Clinical Oncology · 2006 · 350 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.

Manon Huizing, Anther Keung, Hilde Rosing et al. · Journal of Clinical Oncology · 1993 · 313 citations · Full text

Medicine, Oncology, Pharmacology +16